We require your email address in order to send you alerts by email. You can unsubscribe at any time.

You can choose which alerts you receive and can unsubscribe at any time.

Unlock ZYNOCYTE LIMITED's Credit Report?

Unlock The Full Report

  • Credit score, financials and risk data
  • Directors, shareholders and ownership
  • CCJs, payment behaviour and filing history
  • 5 official Companies House documents
  • Instant download and online viewing
  • Email alerts for key changes
  • Personal monitoring dashboard
Buy Now - £20.00
UNLIMITED REPORTS

Unlimited Access For

£35/month

Billed Monthly - Cancel Anytime

Upgrade to Lite

  • 5 credit reports
  • 100 accounts downloads
  • 100 accounts exports

Your plan will start immediately and the time remaining on your existing plan will be refunded

Yes, upgrade to Lite

ZYNOCYTE LIMITED

UK Flag C/O KPMG LLP 3RD FLOOR, 191 WEST GEORGE STREET, GLASGOW, G2 2LJ


Lock icon Download PDF
Credit report booklet

Lock icon Unlock the Full Company Report

  • Check whether this company is legitimate
  • See if this company is likely to run into financial trouble
  • Find out who owns and runs the company
  • Avoid risky business relationships
  • Get instant updates if anything important changes
  • Access official company documents for free

ZYNOCYTE LIMITED

Private limited with Share Capital

Company is dissolved

03 September 1993

72190 Other research and experimental development on natural sciences and engineering - Development of equipment of the veterinary market

Available to 30 Sep 1995. Next accounts due by 30 Jun 1997

Is ZYNOCYTE LIMITED in debt to you?

Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.

Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.

We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.

Remove These Ads

Current Directors & Secretaries

For a full in-depth analysis on each of these directors, click any of the links below

Name Role Date Of Birth Appointed
MR ROGER BARRY CLAMPITT Director
MR GREGORY CALLAN Company Secretary
MR GERALD WHITE Director
MR MICHAEL JOSEPH HOLMES Director
MR JAMES MCMILLAN Director
MR STEPHEN ROBERT HAZELWOOD Director

Previous Directors & Secretaries

Remove These Ads

Mortgages and Charges

Total Outstanding

14

Total Satisfied

1

Type Created Registered Persons Entitled Status
Assignation In Security Of International Patent Application 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Assignation In Security Of Uk Patent Application 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Assignation Of Intellectual Property Rights 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Assignation Of International Patents 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Assignation Of Patent 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Assignation Of Trade Mark 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Assignation Of Trade Marks 3i Group PLC As Agent, Trustee And Investor ; OUTSTANDING
Bond & Floating Charge The Governor And Company Of The Bank Of Scotland ; OUTSTANDING
Bond & Floating Charge Hambros Advanced Technology Trust Ii Limited Partnership ; OUTSTANDING
Bond & Floating Charge 3i Group PLC ; OUTSTANDING
Bond & Floating Charge Hambros Advanced Technology Trust Ii Limited Partnership ; OUTSTANDING
Bond & Floating Charge Hatt Ii (1993) Limited Partnership ; OUTSTANDING
Bond & Floating Charge Murray Ventures PLC ; OUTSTANDING
Bond & Floating Charge Scottish Enterprise ; OUTSTANDING
Bond & Floating Charge Kellock Limited ; SATISFIED
Remove These Ads
Accounts
Cash
Net Worth
Total Current Liabilities
Total Current Assets
Remove These Ads

Frequently Asked Questions about ZYNOCYTE LIMITED

Detailed answers about ZYNOCYTE LIMITED, including incorporation, status, business activity, and accounts information.

When was ZYNOCYTE LIMITED founded?

ZYNOCYTE LIMITED was officially incorporated on 03 September 1993 and is registered under company number SC146252. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.

What type of company is ZYNOCYTE LIMITED?

Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.

What is the current status of ZYNOCYTE LIMITED?

ZYNOCYTE LIMITED's current status is Dissolved. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.

What does ZYNOCYTE LIMITED do?

ZYNOCYTE LIMITED operates in the following sector: 72190 Other research and experimental development on natural sciences and engineering - Development of equipment of the veterinary market . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.

What is ZYNOCYTE LIMITED's registered address?

The registered office address of ZYNOCYTE LIMITED is C/o Kpmg Llp 3rd Floor, 191 West George Street, Glasgow, G2 2LJ. This is the official address filed with Companies House for legal and statutory correspondence.

Is ZYNOCYTE LIMITED financially stable?

Based on the latest accounts up to 30 Sep 1995, ZYNOCYTE LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Jun 1997. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.